Calamos Advisors LLC Amicus Therapeutics, Inc. Transaction History

Calamos Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 12, 2021	SELL	$9.2 - $23.86 $1.53 Million - $3.96 Million	-165,895 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$13.47 - $24.89 $1.27 Million - $2.34 Million	93,948 Added 130.58%	165,895 $3.83 Million
Q3 2020 Oct 26, 2020	BUY	$12.89 - $15.89 $927,396 - $1.14 Million	71,947 New	71,947 $1.02 Million

310

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.